Details of the Drug

General Information of Drug (ID: DMVUXLC)

Drug Name

ST-101

Synonyms

ST 101 [French]; 7-Chloro-1,3-dihydro-5-phenyl-1-trimethylgermyl-2H-1,4-benzodiazepin-2-one; Trimethyl germyl-1, chloro-7, dihydro-1-3, phenyl-5 2H benzodiazepine-1-4 one-2 [French]; 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-trimethylgermyl-; AC1O4GHW; ST 101; LS-34275; Trimethyl germyl-1, chloro-7, dihydro-1-3, phenyl-5 2H benzodiazepine-1-4 one-2

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2	[1]
Anxiety disorder	6B00-6B0Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H12N2O
Canonical SMILES: C1C2=CC=CC=C2CC13C(=O)N=C4N3C=CC=C4
InChI: 1S/C15H12N2O/c18-14-15(17-8-4-3-7-13(17)16-14)9-11-5-1-2-6-12(11)10-15/h1-8H,9-10H2
InChIKey: QZWYXEBIQWJXAR-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 10220323
CAS Number: 887603-94-3
TTD ID: D07CJN

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT00842673) Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease. U.S. National Institutes of Health.